Showing results (81-90 of 142) with videos related to
Sort By:
Pageof 15
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumorsMichael S Gordon, Christopher S Sweeney, David S Mendelson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortiumTanya M Trippett, Cynthia Herzog, James A Whitlock, et al.Acta Neuropathologica Communications|May 21, 2015
Identification of targets for rational pharmacological therapy in childhood craniopharyngiomaJacob M Gump, Andrew M Donson, Diane K Birks, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic studyStephen Leong, Roger B Cohen, Daniel L Gustafson, et al.Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) StudyTodd M Cooper, Jeannette Cassar, Elena Eckroth, et al.Blood|September 15, 2021
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylationMaria L Amaya, Anagha Inguva, Shanshan Pei, et al.Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.JAMA|March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical TrialPatrick A Brown, Lingyun Ji, Xinxin Xu, et al.Pageof 15